SRX Global Inc.
New York Stock Exchange AmericanCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kent Cunningham
- Full Time Employees
- 11
- Sector
- Technology
- Industry
- Software - Application
- Address
- 12400 Race Track Road Tampa FL United States of America 33626
- IPO Date
- Jun 16, 2010
- CIK
- 0001471727
- Website
- srxglobalinc.com
- Similar Companies
- Business
- SRx Health Solutions Inc. SRx Health Solutions Inc. (SRXH) operates as an integrated healthcare services provider in the specialty pharmacy and pet health and wellness sectors across Canada and the United States. The company offers a comprehensive range of services including specialty pharmacy for complex and chronic disease management; infusion clinics and nursing for biologics, iron therapy, and injectable training; patient support programs; wholesale and pharmaceutical distribution from its Health Canada-accredited facility in Mississauga, Ontario; clinical trials sites; compounding services; retail pharmacy operations; travel health consultations with vaccinations and preventive medications; and pet products such as dry food, wet food, treats, supplements, dental products, chews, and vegan options under the Halo brand. With a national footprint in Canada encompassing 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, and an allied health team, SRx Health Solutions serves patients, hospitals, physicians, pharmaceutical manufacturers, and retailers targeting chronic, rare diseases, and everyday healthcare needs. Founded in 2013 and headquartered in Toronto, Canada, the company expanded significantly through its April 2025 business combination with Better Choice Company Inc., which resulted in a name change from Better Choice to SRx Health Solutions Inc., a stock split, rebranding, and NYSE American listing under ticker SRXH; this merger created a global health and wellness entity with projected 2025 revenues exceeding $270 million and positioned SRx securityholders to own approximately 85% of the combined company on a fully diluted basis.
SRX Global Regains Full Compliance with NYSE American Listing Standards
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
SRX Global Declares One-Time Cash Dividend
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
SRX Global Announces Share Consolidation
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)
SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update
SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.